期刊文献+

氨氯地平阿托伐他汀钙片治疗高血压合并冠心病效果分析 被引量:31

Analysis of amlodipine besylate and atorvastatin calcium tablets treatment of hypertension and coronary heart disease
下载PDF
导出
摘要 目的 本文就氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的应用效果进行探讨.方法 选择本院近一年收治的88例高血压合并冠心病患者,按照抽签法分为实验组(n=44)与参照组(n=44),实验组患者采用氨氯地平阿托伐他汀钙片治疗,参照组予以苯磺酸氨氯地平治疗,比较两组患者的血压控制效果及血脂指标.结果 实验组患者的收缩压、舒张压下降程度明显优于参照组,实验组的TC、TG、LDL-C、HDL-C等血脂指标改善程度优于参照组,均 P〈0.05.结论 为合并冠心病的高血压患者采用氨氯地平阿托伐他汀钙片治疗,可有效控制患者血压值,同时还可改善其血脂指标,具有较高的临床推广价值. Objective In this paper,the effect of amlodipine besylate and atorvastatin calcium tablets treatment of hypertension and coronary heart diseasewere discussed.Methods Our hospital treated 88 cases of hypertension in almost one year merger in pa-tients with coronary heart disease,according to the draw method is divided into experimental group (n=44)and control group (n=44),the experimental group were treated by amlodipine atorvastatin calcium treatment,control group to benzene sulfonic acid amlo-dipine treatment,compared two groups of patients with blood pressure control effect and blood lipids index.Results The patients with systolic pressure,diastolic blood pressure decreased significantly better than the control group,experimental group of TC,TG, LDL,HDL-C-C improved blood lipid indexes such as superior to control group,P〈0.05).Conclusion In order to merge coronary heart disease (CHD)patients with high blood pressure with amlodipine atorvastatin calcium treatment,patients can effectively con-trol the blood pressure value,also can improve the blood lipid index,has high clinical value.
作者 周玉龙
出处 《检验医学与临床》 CAS 2017年第A02期108-110,共3页 Laboratory Medicine and Clinic
关键词 氨氯地平阿托伐他汀钙片 高血压 冠心病 效果分析 amlodipine besylate and atorvastatin calcium tablets hypertension coronary heart disease (CHI)) effect analysis
  • 相关文献

二级参考文献58

  • 1陈良,张梅,张运,姚桂华.实时三维超声技术在动脉粥样硬化斑块诊断中的应用[J].中国医学影像技术,2005,21(9):1398-1400. 被引量:16
  • 2范晓红,王春.颈动脉粥样硬化的发病情况及其影响因素的调查与相关分析[J].中华心血管病杂志,2006,34(2):174-175. 被引量:80
  • 3王旋,程龙献,张红梅.细胞因子与冠心病及其危险因素的关系[J].山东医药,2006,46(13):29-30. 被引量:6
  • 4陈新石.高血压患者控制高血压同时降低胆固醇(联合使用络活喜和立普妥)可降低冠心病死亡和心肌梗死发作的风险[J].中华医学杂志,2007,87(10):717-717. 被引量:23
  • 5中国高血压防治指南修订委员会.中国高血压防治指南(第三版)2010年修订版[J].中华高血压杂志,2011,19(8):721-722.
  • 6Czemichow S, Zanchetti A, Turnbull F , et at. The effects of blood pressure reduction and of different blood pressure-lowering regimens on major car?diovascular events according to baseline blood pressure: meta-analysis of randomized trials(J). J Hypertens ,2011 ;29(1) :4-16.
  • 7Conroy RM, Pyooraalaa K, Fitzgerald AP , et at. Estimation of ten -year risk of fatal cardiovascular disease in Europe: the SCORE project[J] . Eur Heart J ,2003 ;24(11) :987-1003.
  • 8De Backer G, Petrella JR, Goudev AR, et at. Design and methodology of POWER, an open-label observation of the effect of primary care interven- tions on total cardiovascular risk in patients with hypertension[J]. Fun?dam Clin Phannacol,2013;27(2) :210-5.
  • 9Turnbull F. Blood pressure lowering treatment trialists' collaboration. Effects of differentblo,?d-pressure-Iowering regimens on major cardiovas?cular events: results of prospectively designed overviews of randomised trialsj J]. Lancet ,2003 ;362(9395) : 1527 -35.
  • 10Ambrosioni E, Bombelli M, Cerasola G, et al. Ambulatory monitoring of systolic hypertension in the elderly: eprosartanlhydrochlorothiazide com?pared with losartanlhydrochlorothiazide(INSIST trial)[J] . Adv Ther, 2010 ;27(6) :365-80.

共引文献494

同被引文献130

引证文献31

二级引证文献165

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部